- Home
- CAT vs AMGN Comparison
CAT vs AMGN Comparison
Compare CAT & AMGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAT
- AMGN
- Stock Information
- Founded
- CAT 1925
- AMGN 1980
- Country
- CAT United States
- AMGN United States
- Employees
- CAT N/A
- AMGN N/A
- Industry
- CAT Construction/Ag Equipment/Trucks
- AMGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAT Industrials
- AMGN Health Care
- Exchange
- CAT Nasdaq
- AMGN Nasdaq
- Market Cap
- CAT 159.3B
- AMGN 156.2B
- IPO Year
- CAT N/A
- AMGN N/A
- Fundamental
- Price
- CAT $294.25
- AMGN $277.29
- Analyst Decision
- CAT Buy
- AMGN Buy
- Analyst Count
- CAT 15
- AMGN 20
- Target Price
- CAT $351.50
- AMGN $324.32
- AVG Volume (30 Days)
- CAT 3.6M
- AMGN 3.7M
- Earning Date
- CAT 04-30-2025
- AMGN 05-01-2025
- Dividend Yield
- CAT 1.92%
- AMGN 3.43%
- EPS Growth
- CAT 9.59
- AMGN N/A
- EPS
- CAT 22.05
- AMGN 7.56
- Revenue
- CAT $64,809,000,000.00
- AMGN $33,424,000,000.00
- Revenue This Year
- CAT N/A
- AMGN $7.36
- Revenue Next Year
- CAT $4.88
- AMGN $2.30
- P/E Ratio
- CAT $13.34
- AMGN $36.68
- Revenue Growth
- CAT N/A
- AMGN 18.57
- 52 Week Low
- CAT $267.30
- AMGN $253.30
- 52 Week High
- CAT $418.50
- AMGN $346.85
- Technical
- Relative Strength Index (RSI)
- CAT 39.44
- AMGN 36.23
- Support Level
- CAT $287.61
- AMGN $267.40
- Resistance Level
- CAT $302.48
- AMGN $296.17
- Average True Range (ATR)
- CAT 14.58
- AMGN 12.41
- MACD
- CAT -0.43
- AMGN -2.02
- Stochastic Oscillator
- CAT 39.03
- AMGN 20.78
About CAT Caterpillar Inc.
Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Its reporting segments are: construction industries (40% sales/47% operating profit, or OP), resource industries (20% sales/19% OP), and energy & transportation (40% sales/34% OP). Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has global reach (46% US sales/54% ex-US). Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of 156 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.
About AMGN Amgen Inc.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.